The Crim1 gene encodes a transmembrane protein containing six cysteine-rich repeats similar to those found in the BMP antagonist, chordin (chd). To investigate its physiological role, zebrafish crim1 was cloned and shown to be both maternally and zygotically expressed during zebrafish development in sites including the vasculature, intermediate cell mass, notochord, and otic vesicle. Bent or hooked tails with U-shaped somites were observed in 85% of morphants from 12 hpf. This was accompanied by a loss of muscle pioneer cells. While morpholino knockdown of crim1 showed some evidence of ventralisation, including expansion of the intermediate cell mass (ICM), reduction in head size bent tails and disruption to the somites and notochord, this did not mimic the classically ventralised phenotype, as assessed by the pattern of expression of the dorsal markers chordin, otx2 and the ventral markers eve1, pax2.1, tal1 and gata1 between 75% epiboly and six-somites. From 24 hpf, morphants displayed an expansion of the ventral mesoderm-derived ICM, as evidenced by expansion of tal1, lmo2 and crim1 itself. Analysis of the crim1 morphant phenotype in Tg(fli:EGFP) fish showed a clear reduction in the endothelial cells forming the intersegmental vessels and a loss of the dorsal longitudinal anastomotic vessel (DLAV). Hence, the primary role of zebrafish crim1 is likely to be the regulation of somitic and vascular development. q
Introduction
In vertebrates, the specification of the future dorsoventral (DV) and anterior-posterior cell fates takes place during early embryonic development. In zebrafish, the mechanisms of DV patterning appear largely conserved with Xenopus. Mutational and knockdown studies have identified a number of genes that are integral to this process (Hammerschmidt et al., 1996a) . The majority of these are members of the TGF-b/BMP signalling pathway and their regulators. The strongly dorsalised mutants swirl and snailhouse are loss-of-function mutants of bmp2b and bmp7, respectively (Dick et al., 2000; Kishimoto et al., 1997) . The dorsalised mutants lost-a-fin and somitabun encode members of the TGF-b signalling cascade: alk8 (BMP type I receptor) and smad5 (Bauer et al., 2001; Hild et al., 1999; Mintzer et al., 2001) . In contrast, the ventralised mutant dino, results from a deficiency in chordin (chd), which encodes a dorsally expressed factor that inhibits BMP signalling by direct binding in the extracellular matrix (Piccolo et al., 1996; Schulte-Merker et al., 1997) . From this evidence, it has been proposed that DV axis specification in zebrafish requires a gradient of BMP signalling which is shaped by a dorsal to ventral gradient of Chordin and ventral expression of BMPs and Tolloid (Schier, 2001) .
CRIM1 is a member of the Chd-like cysteine rich repeat (CRR) family of proteins . Proteins containing these repeats are involved in regulation of BMP/ TGF-b signalling (Garcia-Abreu et al., 2002) . In particular, several family members including Chd, CTGF, procollagen type II and Neuralin1/Ventroptin, are secreted proteins that bind to members of the TGF-b superfamily and inhibit or promote their activity in the extracellular matrix (Garcia-Abreu et al., 2002; Nakayama et al., 2001; Piccolo et al., 1996; Sakuta et al., 2001; Zhu et al., 1999) .
Experiments in Xenopus have revealed that BMPs are not able to diffuse over long distances in the ventral mesoderm (Jones et al., 1996) . The rate of processing and secretion of BMPs is mediated in part by pro-domain sequences (Constam and Robertson, 1999; Wilkinson et al., 2003) . We have shown that, like Chd, CRIM1 is able to interact with members of the BMP family (BMP4 and BMP7) using in vitro assay systems (Constam and Robertson, 1999; Wilkinson et al., 2003) . However, unlike Chd, CRIM1 contains a transmembrane domain and therefore does not appear to act by simple extracellular antagonism. We have also shown that CRIM1, when co-expressed with BMP in cell lines, appears to restrict the amount of active BMP that is secreted into media in vitro (Constam and Robertson, 1999; Wilkinson et al., 2003) . This occurs due to a regulation of the processing of preBMPs by CRIM1. Co-expression of CRIM1 with BMPs decreases preBMP preprotein cleavage and tethers the preprotein to the cell surface (Constam and Robertson, 1999; Wilkinson et al., 2003) .
During mouse and chick development, Crim1 expression is localised to specific regions consistent with a role in BMP regulation including the notochord and ventral neural tube, the lens of the eye and the developing kidney Kolle et al., 2000; Lovicu et al., 2000) . However, the in vivo function of Crim1 has yet to be determined. In order to investigate the physiological role of CRIM1, we have cloned the zebrafish ortholog, crim1, and shown that it is maternally and zygotically expressed, but that it does not show a dorsal site of expression like other known BMP inhibitors. Using morpholino knockdown, we then show that lack of crim1 produces specific defects of the tail somites and an expansion of the intermediate cell mass, similar to the chordin hypomorph 'captain hook'. Analysis of this phenotype via injection of morpholino into transgenic fli:EGFP (Tg(fli:EGFP)) fish highlights additional disruptions to the development of the vasculature of these morphants. While these results may be interpreted as weak ventralisation, they do not suggest a primary role for crim1 in DV patterning but highlight several distinct roles for this gene in the development of the vasculature and the somites.
Results

Characterisation of a CRIM1 ortholog in zebrafish
To examine whether this gene is involved in axis formation in vivo, we first isolated the full-length coding sequence of zebrafish crim1 (crim1, Genbank no. AY151045) using a combination of genetic sequence analysis of the publicly available unfinished zebrafish genome sequence (http://www. trace.ensembl.org/) and RT-PCR of whole zebrafish embryos at 48 hours post fertilisation (hpf). CRIM1 encodes a protein of 1036 amino acids with 69/68/70% overall identity to human/ mouse/chicken CRIM1 and 30% to C. elegans crim1-like protein B0024.14 . Like other vertebrate CRIM1 proteins, zebrafish Crim1 contains a signal peptide, an IGFBP-like domain, six CRR domains, a transmembrane domain and a short cytoplasmic domain (Fig. 1A) .
Expression of crim1 in zebrafish
To determine the temporal expression of crim1 during zebrafish development, we first performed a multiple stage reverse transcription polymerase chain reaction (RT-PCR). crim1 transcripts were observed at all stages from early blastula up to 48 hpf (Fig. 1B) . This suggests that crim1 transcripts are both maternally and zygotically expressed (Kane and Kimmel, 1993) . RNA in situ hybridisation on whole zebrafish embryos revealed expression of crim1 in early pre-gastrulation embryos (16-cell and sphere stages) and early segmentation (six-somite) when expression was observed in a diffuse pattern along the entire anterior-posterior axis ( Fig. 1(C-H) ). From the 10-somite stage to 21 hpf crim1 expression is seen in the notochord. However, this expression does not extend to the rostral or caudal margin over these developmental stages ( Fig. 1I-N (Westerfield, 1995) ). By 24 hpf, expression of crim1 in the notochord was restricted to a few cells in the tail and was completely absent by 30 hpf (Fig. 1O, P) . crim1 expression was also noted in several other regions of late segmentation and early pharyngeal stages including the brain. crim1 was detected in the otic vesicle at and before 30 hpf (Fig. 1P , data not shown). crim1 was also expressed in the intermediate cell mass (ICM) (Fig. 1O , P, arrows). In addition, transient expression was observed in a pattern reminiscent of the posterior cardinal vein (PCV) at 24 hpf (Fig. 1O 0 ) (Lawson and Weinstein, 2002a) , suggesting that crim1 may be present in angioblasts. Overall, expression of crim1 in zebrafish was consistent with previous reports in human, mouse and chicken revealing expression in several developmental tissues and organs including the notochord, otic vesicle and blood vessel precursors (Glienke et al., 2002; Kolle et al., 2000 Kolle et al., , 2003 .
Characterisation of the crim1 morphant phenotype
To determine the role of crim1 during zebrafish early development, we knocked-down crim1 using two independent morpholinos (MO) (Summerton, 1999) designed against the start site (crim1A-MO) and 5 0 untranslated regions (crim1B-MO) of the zebrafish crim1 cDNA ( Fig. 2A) . To confirm the efficacy of the morpholino approach, crim1A-MO was coinjected with a green fluorescent protein (GFP) reporter containing the start site sequence of crim1 (Fig. 2B) . crim1A-MO specifically knocked-down expression of GFP from this RNA transcript as revealed at 30 hpf in 100% of embryos (nZ169) (Fig. 2B ). In comparison, there was no Von Willebrand factor C type repeats; T, transmembrane domain; (B) crim1 positive signal was observed at non-saturation PCR conditions at all stages examined from blastula (256-1K cell) to 48 hpf. cDNA specific primers amplifying the ubiquitously expressed elongation factor-1 alpha (EF1a) was used as a loading control (Nordnes et al., 1994) . detectable knockdown of GFP when co-injected with a random control morpholino (nZ142) (Fig. 2B ). This revealed the ability of the crim1A-MO to inhibit protein production from its target sequence. The graph in Fig. 3A shows there is a reduction in the pigtail and severe phenotypes and increase in the mild phenotype at decreasing crim1A-MO concentrations. crim1A-injected embryos displayed either mild hook/bent-tailed, pig-tail or severe phenotypes as shown by the representative images in Fig. 3B . The pig-tail embryos have a twisted tail, while the severe phenotype is characterised by a grossly expanded ICM. All phenotypes, including mild, have a bent-tail and an expanded ICM (Fig. 3B) . Almost all embryos with a mild phenotype will survive to hatching stage. Non-specific abnormal phenotypes (2%) were not observed at a greater rate than control-MO. Injection of crim1B-MO was sufficient to phenocopy the mild crim1A-MO phenotypes at a similar penetration (80%, nZ201, data not shown). At 48 hpf, most embryos that survived displayed a hook-tail phenotype as compared to wild-type animals ( Fig. 3D 0 , D, respectively).
While injection of both crim1 morpholinos resulted in a significantly larger number of embryos exhibiting mutant phenotypes, the crim1A-MO appeared to act more potently than crim1B-MO. The evidence that two morpholinos give equivalent phenotypes, and the fact that crim1A-MO effectively inhibited protein expression from its target site, confirms the specificity of the crim1 morpholinos. Consequently, we present here data obtained from embryos injected with the crim1A-MO, which we refer to as crim1 morphants. Analysis of the crim1 morphants revealed some similarities with previously published ventralised mutants (Hammerschmidt et al., 1996b) . At 20-30 hpf crim1 morphants had an expanded intermediate cell mass, abnormal tail somites and smaller head and eyes compared to control-MO injected embryos (Fig. 3) . These phenotypic variations are consistent with weakly ventralised (V1-V2) mutants such as ogon/mercedes or weak alleles of chordino (Hammerschmidt et al., 1996b; Kishimoto et al., 1997) . However, these embryos did not show an expansion of ventral tail fin. Greater than 90% of all crim1 morphants had U-shaped tail somites posterior to the bend of the tail suggesting defects in slow muscle development in this region (Fig. 3, mild ) van Eeden et al., 1996) . Another defect observed in the crim1 morphants was absent or irregular blood circulation. All morphants displaying the crim1 phenotype have either no blood circulation (Fig. 3 , pig-tail and severe) or a decrease and an irregularity of the blood flow through the embryo.
crim1 morphants show no changes in expression of dorsoventral markers
To determine whether the knockdown of crim1 affects markers of DV patterning at earlier stages, we examined the expression of various ventral and dorsal markers at late gastrula and early segmentation stages (Fig. 4) . There was no obvious difference in the expression of the ventral markers eve1 (Fig. 4A, A 0 ), tal1 (Fig. 4F, F 0 , G and G 0 ), gata1 (Fig. 4H, H  0 ) , and pax2.1 (Fig. 4J , J 0 , K and K 0 ) between the crim1 morphants and controls although there appeared to be a slight overall delay in the development of aged-matched morphants compared to the control-injected wildtypes. The same applied for the dorsal markers otx2 (Fig. 4B , B 0 ), chd (Fig. 4C , C 0 ) and myoD (Fig. 4I, I  0 ). There was a consistently weaker expression 
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of tal1. In total, this data suggests that crim1 is not involved in DV patterning.
crim1 morphants have expanded expression of haematopoietic markers
As chd mutants show an expanded ICM, we wanted to see if crim1 morphants show an equivalent phenotype. We examined the distribution of specific haematopoietic precursor (tal1, lmo2) and vascular precursor (gdf6a/radar, flk1) cell markers. These cells are all derivatives of the ventrolateral mesoderm and ICM (Gering et al., 1998; Thompson et al., 1998) . In addition, we examined the expression pattern of crim1 itself, which we have shown to mark the ICM and early blood vessels (this study). Most of these markers demonstrated an expansion of their expression domains in crim1 morphants compared to controls at 24 hpf (Fig. 5) . Conversely, there was not an expansion of bmp4 expression in the ICM of the crim1 morphants (Fig. 5F 0 ), suggesting that the ICM expansion is not due to an upregulation of BMP4, and that the cells within the ICM are not of a monocytic lineage (Leung et al., 2005) . The enhanced expression of crim1 can also be interpreted as a stabilisation of the crim1 transcript in response to the MO, as has previously been demonstrated (Oates and Ho, 2002) . This was most striking in the ICM, but in addition there was ectopic expression of all genes in the trunk of the embryo consistent with the location of precursors for the posterior cardinal vein and the dorsal artery. This increase is consistent with the expansion of the ventrolateral mesoderm during gastrulation, but may also imply a disruption to vascular development. 
crim1 morphants display notochord constriction, U-shaped somites and loss of muscle pioneer cells
To determine if there was a reduction of dorsally derived tissue, we analysed the expression of the notochord marker shh. It has been shown that in ventralised embryos there is often a loss or narrowing of the notochord at the caudal end of the embryo (Hammerschmidt et al., 1996b) . In crim1 morphants there is no absence of shh expression along the anteriorposterior axis. However, in a majority of embryos (80%, nZ 20), there was a narrowing of the notochord and a reduction in the size of the tail bud as revealed by shh staining at 26 hpf (Fig. 5G,G 0 ). To further confirm a defect in notochord, we stained morphant embryos for a marker of muscle pioneer cells, En1 (Ekker et al., 1992) . These paraxial muscle cells require a functional notochord and the highest levels of shh expression . In crim1 morphants, a majority of embryos (75%, nZ22) had no En1 positive cells in three to seven of the caudal-most somites as compared to wildtype at 28 hpf (nZ22, Fig. 5H ,H 0 ). These results confirm a reduction in notochord tissue and muscle pioneer cells in the crim1 morphants, which is consistent with the observation of U-shaped tail somites, but not broadly consistent with ventralisation.
crim1 morphants display blood vessel defects
The enlarged ICM and reduction in circulating blood cells in crim1 morphants suggested that there was a vascular defect present. As evidence suggests that crim1 is expressed in blood vessels, crim1A-MO was injected into Tg(fli:EGFP) embryos and analysed post 48 hpf. There was a reduction in the intensity of GFP in the crim1A-MO injected embryos suggesting this may be indicative of a reduction in the number of endothelial cells (Fig. 6A 0 , crim1 morphants on right-hand side of panel). Structural differences between normal vessel development ( Fig. 6D ) and in the morphants is shown by the disorganised patterning of the intersegmental vessels (Se) and the malformation of the dorsal longitudinal anastomotic vessel (DLAV) and parachordal vessels (PAV) in the crim1A-MO injected embryos (Fig. 6E 0 ) (Isogai et al., 2001 ). The expanded ICM (Fig. 6G) contains and also is surrounded by Tg(fli:EGFP) positive cells suggesting that this region contains cells of an endothelial lineage. 
Discussion
The Crim1 gene encodes a protein with multiple chd-like cysteine rich repeats, defined recently as a TGF-b interacting domain (Garcia-Abreu et al., 2002) . We have shown in vitro that Crim1 can interact with TGF-b superfamily proteins, in particular members of the BMPs (Wilkinson et al., 2003) . In this study, we have analysed the function of crim1 in zebrafish using morpholino knockdown. While our studies show that the knockdown of crim1 does not cause classical ventralisation, crim1 morphants show an expansion of the ventral mesodermderived intermediate cell mass and a concomitant disruption to the onset of normal blood circulation. This is similar to, but less severe than, the expansion of the posterior blood island seen in chordin morphants (Leung et al., 2005) . Reduction in crim1 also results in a loss of muscle pioneer cells, a disruption to the caudal notochord, U-shaped tail somites and a bent/hooked tail phenotype.
BMPs in the development of the intermediate cell mass
When first described by Hammerschmidt et al. (1996b) , the dino mutant was described as having expanded 'blood islands' or ICM. While ventralisation can be measured by features such as altered gene expression and a reduction in head structures, the dino mutant was thought to result from a loss of BMP antagonism. In chd morphants, the specific role of BMPs in the posterior blood island has only recently been investigated (Leung et al., 2005) . It has now been shown that chd morphants overexpress BMP4 and Smad5 within the blood island, with BMP4 activity causing this aspect of the phenotype (Leung et al., 2005) . Our analyses do not reveal BMP4 overexpression. In addition, we have shown a greater affinity of Crim1 for BMP7 (Wilkinson et al., 2003) . There are other members of the TGFb superfamily known to be involved in normal haemangiogenesis. These include radar, which also showed an expanded area of expression in crim1 morphants and may be a crim1 ligand.
crim1 morphants show features similar to 'captain hook'
The most obvious and consistent phenotype observed in the crim1 morphants was the development of a bent or hooked tail from 20 hpf. This phenotype mimics that of the 'captain hook' mutants first described in the large-scale genetic screen for embryonic lethal mutations in zebrafish (Mullins et al., 1996) . There are six alleles of 'captain hook'; m52, m70, m282, m362, m586 and m169. m586 and m169 have been shown to be chordin hypomorphs and Smad5 amorphs, respectively. In addition, Mullins et al. (1996) have reported a 'captain hook' phenotype in chordin morphants (Mullins et al., 1996) . This is somewhat surprising given the fact that Chordin is presumed to antagonise signalling via Smads, such as Smad5. Such observations question the current model of Chordin as a BMP antagonist and do not clarify whether crim1 is acting as an agonist or antagonist of BMP signalling (Wagner and Mullins, 2002) .
crim1 in embryonic patterning
While the phenotype of crim1 morphants does not suggest a simple disruption to DV patterning, there are some features of these morphants that do imply a disruption in patterning, including the U-shaped somites, shortening of body length and frank expansion of at least one ventral mesoderm-derived compartment, the posterior blood island. The recent debate about the rostral-caudal axis has suggested the need to reinterpret a number of zebrafish mutants described as affecting dorsal-ventral axial patterning (Lane and Sheets, 2000; Lane and Smith, 1999) . The presence of U-shaped tail somites suggests a U-type mutant. All such mutants described to date impact on the hedgehog pathway (Lewis et al., 1999) . Induction of the muscle pioneer cells is mediated by sonic hedgehog signalling from the notochord (Halpern et al., 1993) . While there is no evidence that CRR-containing proteins such as crim1 play any part in Shh action or stability, it is possible that this defect indicates a need for BMP antagonism within the notochord for normal muscle pioneer cells patterning. A better understanding of the physiological ligand/s of crim1 is needed to explain the phenotype observed. Additionally, this feature of the crim1 morphants may simply arise as result of cell death in the notochord and spinal cord due to increased levels of apoptosis, resulting in a reduction in Shh expression. This is supported by the observation that the U-shaped somites and lack of muscle pioneer cells are seen adjacent to a region of the notochord that is morphologically abnormal and displaying less Shh expression.
Vascular defects in crim1 morphants
The intersegmental vessels arise from angioblasts along the dorsal aorta via Type II vasculogenesis (angioblastic vessel sprouting) (Staton et al., 2004) . These cells migrate between the somites in the ventral portion of the tail and then move into the middle of the somite before fusing dorsally to form the DLAV (Childs et al., 2002) . Morphant fish showed a distinct reduction in intersegmental vessels and appeared to be lacking DLAV formation. This may result from a reduction in angioblasts and/or endothelial cells, a defect in cell fate determination, in their migration and/or their ultimate vascular integrity. Glienke et al. (2002) demonstrated that the loss of Crim1 expression in human umbilical endothelial cell cultures disrupts vessel formation in vitro. This would tend to support a defect in vessel maturation or endothelial cell migration rather than endothelial cell determination. The lack of alteration to BMP4 expression within the ICM does not support an expansion of haematopoietic cells as is seen in chordin morphants (Leung et al., 2005) . Hence, while crim1 expression is present during haemangiogenesis, the primary defect in this organ system seems to be vascular. The presence of U-shaped somites implies a disruption to slow muscle fibre development similar to that seen in sonic-you mutants. Brown et al. (2000) have suggested that sonic-you mutants also show disruptions to blood vessel development. However, the constriction of the caudal notochord and lack of muscle pioneer cells from this point on appears to result from a distinct crim1 activity as the disruption to vascular patterning affects the entire length of the fish.
In conclusion, in this study we have demonstrated that a knockdown of crim1 results in an expansion of the ventral mesoderm-derived posterior blood island, with a concomitant disruption to the onset of normal blood circulation. While chordin morphants also display an expansion of the intermediate cell mass, the expression pattern of crim1 coupled with the overall phenotype of crim1 morphants does not support a primary role for this gene product in DV patterning. The observed morpholino-specific loss of muscle pioneer cells, U-shaped tail somites and a bent/hooked tail phenotype implies an earlier role for crim1 in the normal development of the somites, while the expansion of the intermediate cell mass and defects in circulation support a role for crim1 in haemangiogenesis.
Materials and methods
Zebrafish
Danio rerio were maintained by staff at the Institute for Molecular Bioscience and at the Centre for Functional and Applied Genomics (The University of Queensland). The Tg(fli1:EGFP) y1 zebrafish line used in this study has been described elsewhere (Lawson and Weinstein, 2002b) . Embryos were collected and grown in E3 media (5 mM NaCl, 0.17 mM KCl, 0.4 mM CaCl 2 , and 0.16 mM MgSO 4 ) at 28.5 8C for accurate growth and staging of the zebrafish embryo as described by Kimmel et al. (1995) .
Cloning zebrafish crim1
Zebrafish crim1 was amplified from 48 h post fertilisation whole embryos, with primers designed to sequence information gained from genomic sequence traces available at http://trace.ensembl.org/.
Developmental RT-PCR
Zebrafish crim1 specific RT-PCR was performed on RNA from dechorionated zebrafish embryos with crim1 1F (5 0 -CGGAGTGGAGTAC-CATGATG-3 0 ) and crim1 2R (5 0 -ACCTCGGTCTCACACAGCAC-3 0 ) primers for 27 cycles. Zebrafish elongation factor 1 alpha (EF1a) was used as a loading control (Nordnes et al., 1994) .
Whole mount in situ hybridisation and antibody staining
In situ hybridisation was performed as described (Westerfield, 1995) . Zebrafish crim1 probe was produced from clone crim1 1F2R (bases 1041 to 2068, Genbank accession no. AY151045). In situ markers: zebrafish shh (Krauss et al., 1993) , tal1 (scl1) (Gering et al., 1998) , lmo2 (Thompson et al., 1998) , eve1 (Joly et al., 1993) , otx2 (Mori et al., 1994) , MyoD (Weinberg et al., 1996) , gata1 (Mead et al., 2001) , chordin (Miller-Bertoglio et al., 1997) , gdf6a/radar and flk1 (Liang et al., 2001) , and bmp4 (Leung et al., 2005) have been previously described. Antibody labelling was done as previously described (Westerfield, 1995) using Engrailed-1 specific monoclonal antibody 4D9 (Patel et al., 1989) . 
Morpholinos
Injections
One-cell wildtype or transgenic Fli:EGFP zebrafish embryos were injected with capped mRNA or morpholino into the yolk as described by Westerfield (1995) .
